(Q34576416)

3 August 2017

1 reference

title

Chemokines: agents for the immunotherapy of cancer? (English)

1 reference

3 August 2017

1 reference

3

Albert Zlotnik

1 reference

3 August 2017

Bernhard Homey

1

1 reference

PubMed ID

11913068

3 August 2017

Anja Müller

series ordinal

2

1 reference

3 August 2017

1 March 2002

1 reference

Nature Reviews Immunology

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

175-184

1 reference

3 August 2017

3

1 reference

Lymphocyte homing and homeostasis

3 August 2017

1 reference

21 January 2018

Chemokines in allergy

1 reference

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

Dendritic cell biology and regulation of dendritic cell trafficking by chemokines

21 January 2018

1 reference

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

21 January 2018

1 reference

Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC)

21 January 2018

1 reference

CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells

21 January 2018

1 reference

The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells

21 January 2018

1 reference

Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues

21 January 2018

1 reference

Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium.

21 January 2018

1 reference

Diverse transcriptional response of CD4+ T cells to stromal cell-derived factor SDF-1: cell survival promotion and priming effects of SDF-1 on CD4+ T cells

21 January 2018

1 reference

Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

21 January 2018

1 reference

Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer

21 January 2018

1 reference

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells

21 January 2018

1 reference

Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro

21 January 2018

1 reference

Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins

21 January 2018

1 reference

Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer

21 January 2018

1 reference

The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor

21 January 2018

2 references

21 January 2018

inferred from DOI database lookup

7 January 2021

based on heuristic

The functional role of the ELR motif in CXC chemokine-mediated angiogenesis

1 reference

The microenvironment of the tumour-host interface

21 January 2018

1 reference

Chemokines and the molecular basis of cancer metastasis

21 January 2018

1 reference

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration

21 January 2018

1 reference

A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice

21 January 2018

1 reference

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations

21 January 2018

1 reference

The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells

21 January 2018

1 reference

Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth

21 January 2018

1 reference

Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo

21 January 2018

1 reference

Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms

21 January 2018

1 reference

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

21 January 2018

1 reference

Dendritic cells and the control of immunity

21 January 2018

1 reference

21 January 2018

1 reference

Dendritic cells as vectors for therapy

21 January 2018

1 reference

Lymphotactin: a cytokine that represents a new class of chemokine

21 January 2018

1 reference

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models

21 January 2018

1 reference

Inhibition of angiogenesis in vivo by interleukin 12.

21 January 2018

1 reference

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

21 January 2018

1 reference

Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity

21 January 2018

1 reference

Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers

21 January 2018

1 reference

Interleukin-2 in cancer treatment: disappointing or (still) promising? A review

21 January 2018

1 reference

Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes

21 January 2018

1 reference

Clinical trials of antibody therapy

21 January 2018

1 reference

Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms

21 January 2018

1 reference

Regulatable systems: applications in gene therapy and replicating viruses

21 January 2018

1 reference

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

21 January 2018

1 reference

Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer

21 January 2018

1 reference

Advances in cancer immunotherapy

21 January 2018

1 reference

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

21 January 2018

1 reference

Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production

21 January 2018

1 reference

A chemokine-driven positive feedback loop organizes lymphoid follicles

21 January 2018

1 reference

Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo

21 January 2018

1 reference

Surrogate markers of response to cancer immunotherapy

21 January 2018

1 reference

Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines

21 January 2018

1 reference

Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells

31 March 2020

1 reference

Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells

31 March 2020

1 reference

Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin

31 March 2020

1 reference

Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma

31 March 2020

1 reference

Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes

31 March 2020

1 reference

Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor

31 March 2020

1 reference

A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells.

31 March 2020

1 reference

CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors

31 March 2020

1 reference

Combined chemokine and cytokine gene transfer enhances antitumor immunity

31 March 2020

1 reference

Interleukin-12: a cytokine at the interface of inflammation and immunity

31 March 2020

1 reference

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

31 March 2020

1 reference

Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI748

1 reference

3 August 2017

1 reference

PubMed ID

11913068